Dynamic contrast-enhanced MRI for response evaluation of non-small cell lung cancer in therapy with epidermal growth factor receptor tyrosine kinase inhibitors: a pilot study

  • Kim, Jae-Hun; 
  • Lee, Ju Won; 
  • Park, Keunchil; 
  • Ahn, Myung-Ju; 
  • Moon, Jung Won; 
  • 외 2명
Citations

WEB OF SCIENCE

7
Citations

SCOPUS

7

초록

Background: It is important to identify candidates who would benefit from target agent chemotherapy in advanced NSCLC patients. The purpose of this study is to evaluate the feasibility of DCE-MRI for early response evaluation in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) treatment in patients with NSCLC. Methods: Seven patients were prospectively enrolled who have pathologically-proven NSCLC with EGFR mutations or at least 2 of the following factors; adenocarcinoma, female, or never-smokers. Patients were treated with gefitinib or erlotinib and the start of chemotherapy was denoted day 0. DCE-MRI was performed at day-1, day+7, and day+28. Longitudinal changes of perfusion parameters were quantified and compared to Response Evaluation Criteria in Solid Tumors (RECIST) results. Results: Quantitative perfusion parameters; K-trans, v(e) and v(p) of the lung cancer showed a significant decrease at day+7 (P=0.016), but no further significant decrease between day+7 and day+28 (P>0.05). Semi-quantitative markers for tumor enhancement curve pattern; EA (enhancement amplitude), MS (maximum slope), and AUC (area under the curve) also showed a significant decrease at day+7 (P=0.016, 0.031, and 0.016, respectively), but no further significant decrease between day+7 and day+28 (P>0.05). When RECIST applied, all patient was in the stable disease at day+7 and three patients showed partial response (PR) at day+28. All seven patients showed PR by the 3-month follow-up. Conclusions: Perfusion parameters may be used as an early non-invasive imaging biomarker for the response evaluation of target agent treatment in NSCLC.

키워드

Non-small cell lung cancer (NSCLC); perfusion magnetic resonance imaging (MRI); tumor angiogenesis; SOLITARY PULMONARY NODULES; TUMOR RESPONSE; DCE-MRI; GEFITINIB; BIOMARKERS; PARAMETERS; MUTATIONS; ERLOTINIB; TRACER; IRESSA
제목
Dynamic contrast-enhanced MRI for response evaluation of non-small cell lung cancer in therapy with epidermal growth factor receptor tyrosine kinase inhibitors: a pilot study
저자
Kim, Jae-Hun; Lee, Ju Won; Park, Keunchil; Ahn, Myung-Ju; Moon, Jung Won; Ham, Soo-Youn; Yi, Chin A.
DOI
10.21037/apm-19-622
발행일
2021-02
유형
Article
저널명
Annals of Palliative Medicine
권
10
호
2
페이지
1589 ~ 1598